• Patent Title: Self-administered, non-invasive, transcutaneous viral detector
  • Application No.: US17079649
    Application Date: 2020-10-26
  • Publication No.: US11304605B2
    Publication Date: 2022-04-19
  • Inventor: Allen B. ChefitzRohit Singh
  • Applicant: 123IV, Inc.
  • Applicant Address: US NY New Rochelle
  • Assignee: 123IV, Inc.
  • Current Assignee: 123IV, Inc.
  • Current Assignee Address: US NY New Rochelle
  • Agent David H. Judson
  • Main IPC: A61B5/00
  • IPC: A61B5/00
Self-administered, non-invasive, transcutaneous viral detector
Abstract:
A non-invasive, transcutaneous, real-time viral detection device that is configured for self-administration, e.g., at a user's home. In one embodiment, and after positioning the device relative to the human body part (e.g., the user's finger), light sources in the device are activated (excited), and resulting data captured. In particular, a set of Raman spectra are collected from a configured set of emitters and detectors in the device and delivered to a nearby receiver, preferably wirelessly. The receiver filters and de-convolves the Raman spectra producing a data set representative of the constituent elements in the user's tissue of interest. The data set is applied against a statistical classifier, e.g., a neural network that has been trained to recognize and distinguish the absence or presence of viral components, e.g., C-19, or its associated blood-borne acute phase reactants. The classifier outputs an appropriate indicator, preferably in real-time, providing the user with an immediate indication of whether C-19 (or other virus of interest) is present.
Public/Granted literature
Information query
Patent Agency Ranking
0/0